SCHEMBL1483715

SCHEMBL1483715

N/C(=N/O)c1ccc(NC(=O)C(F)(F)Cl)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 6/20 0.38
KMT2A Q03164 2/20 0.37
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
KCNE1 P15382 1/20 0.36
KCNQ1 P51787 1/20 0.36
NAMPT P43490 1/20 0.36
MEN1 O00255 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HDAC3 O15379 4/20 0.35
HDAC1 Q13547 4/20 0.35
HDAC8 Q9BY41 3/20 0.35
HDAC4 P56524 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1483716 1.00 P4HTM (0.38) P4HTMKMT2AKCNQ3KCNQ2KCNE1
SCHEMBL1483568 0.78 HDAC3 (0.40) P4HTMNAMPTNPC1RAB9AALDH1A1
SCHEMBL1483570 0.78 HDAC3 (0.40) P4HTMNAMPTNPC1RAB9AALDH1A1
SCHEMBL1483636 0.78 KDM4E (0.52) KMT2ANAMPTMEN1NPC1RAB9A
SCHEMBL1483635 0.78 KDM4E (0.52) KMT2ANAMPTMEN1NPC1RAB9A
SCHEMBL1484387 0.72 HDAC3 (0.50) P4HTMKMT2ANPC1ALDH1A1GAA
SCHEMBL1484386 0.72 HDAC3 (0.50) P4HTMKMT2ANPC1ALDH1A1GAA
SCHEMBL1483200 0.71 HDAC3 (0.67) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL1483199 0.71 HDAC3 (0.67) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL1483890 0.70 AR (0.60) KCNQ3KCNQ2KCNE1KCNQ1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314103-B2 Pyridyl derivatives, their preparation and use Piramal Enterprises Limited (IN) 2012-11-20 US claimed
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE Piramal Enterprises Limited (IN) 2011-03-31 US claimed
US-8314103-B2 Pyridyl derivatives, their preparation and use Piramal Enterprises Limited (IN) 2012-11-20 US disclosed
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE Piramal Enterprises Limited (IN) 2011-03-31 US disclosed
WO-2009019656-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2009-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE HIF1AN, HIF1A, MTOR P4HTM 92/4885KMT2A 3868/4885KCNQ3 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.